Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Levofloxacin Pharmacokinetics in the Severely Obese.

Trial Profile

Levofloxacin Pharmacokinetics in the Severely Obese.

Phase of Trial: Phase IV

Latest Information Update: 08 Jun 2018

At a glance

  • Drugs Levofloxacin (Primary)
  • Indications Bacterial infections
  • Focus Pharmacokinetics
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 18 Feb 2009 Planned number of patients changed from 30 to 25 as reported by ClinicalTrials.gov.
    • 18 Feb 2009 Actual end date (Jun 2008) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top